About this trial
The goal of this randomized, double-blind, sham-controlled clinical trial is to evaluate the benefits of home-based, leg heat therapy (HT) on lower-extremity functioning and quality of life in patients who suffer from lower-extremity peripheral artery disease (PAD). We will randomize 106 patients to one of two groups that either receive leg HT or a sham intervention. The primary study outcome is the change in 6-minute walk distance between baseline and the 12-week follow up. Secondary outcomes include changes in the short physical performance battery score, handgrip strength, quality of life (measured by the Walking Impairment Questionnaire and Short-Form (SF)-36 Questionnaire), calf muscle strength (measured using a calf ergometer), size (measured by magnetic resonance imaging) and bioenergetics (assessed using phosphorus-31 magnetic resonance spectroscopy), and physical activity (measured by accelerometer).
Eligibility criteria
Qualifiers
Men and women older than 50 years
Resting ankle-brachial index (ABI) of 0.9 or less in at least one leg. Individuals with a resting ABI between 0.91 and 1.00 at baseline will be eligible if their ABI drops by 20% or greater following a heel-rise test.
Disqualifiers
Critical limb ischemia (ischemic rest pain or ischemia-related, non-healing wounds or tissue loss)
Prior foot or leg amputation
Exercise tolerance limited by factors other than leg pain (e.g. angina, arthritis, severe lung disease, etc).
Recent (<3 months) lower-extremity revascularization or orthopedic surgery
Trial design
Treatments tested in this trial
- Leg heat therapy
- Sham Control
Treatment groups
Sponsors and collaborators
Indiana University
Lead sponsor
Purdue University
Collaborator
National Institute on Aging (NIA)
Collaborator